Search Results - "Zadrazil, J"

Refine Results
  1. 1

    Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice by Šterzl, I, Hill, M, Stárka, L, Velíková, M, Kančeva, R, Jemelková, J, Czerneková, L, Kosztyu, P, ZadraŽil, J, Matoušovic, K, Vondrák, K, Raška, M

    Published in Physiological research (01-01-2017)
    “…Glucocorticoid (GC) therapy is one of the methods of choices for treatment of autoimmune diseases (ADs). In addition, adrenal androgens are known as…”
    Get full text
    Journal Article
  2. 2

    C1q complement component and -antibodies reflect SLE activity and kidney involvement by Horák, P, Hermanová, Z, Zadrazil, J, Ciferská, H, Ordeltová, M, Kusá, L, Zurek, M, Tichý, T

    Published in Clinical rheumatology (01-07-2006)
    “…The role of the complement system in the pathogenesis of systemic diseases is very ambivalent. In systemic lupus erythematosus (SLE), many abnormalities in the…”
    Get full text
    Journal Article
  3. 3

    Expression of nucleic acid binding Toll-like receptors in control, lupus and transplanted kidneys – a preliminary pilot study by Ciferska, H, Horak, P, Konttinen, YT, Krejci, K, Tichy, T, Hermanova, Z, Zadrazil, J

    Published in Lupus (01-06-2008)
    “…We hypothesized that nucleic acids, free and/or complexed, filtered and/or locally released, might be entrapped in the kidneys because of the specific nucleic…”
    Get full text
    Journal Article
  4. 4

    Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study by Zavada, J., Pešickova, SS, Ryšava, R., Olejarova, M., Horák, P., Hrnčíř, Z., Rychlík, I., Havrda, M., Vítova, J., Lukáč, J., Rovensky, J., Tegzova, D., Böhmova, J., Zadražil, J., Hána, J., Dostál, C., Tesar, V.

    Published in Lupus (01-10-2010)
    “…Intravenous cyclophosphamide is considered to be the standard of care for the treatment of proliferative lupus nephritis. However, its use is limited by…”
    Get full text
    Journal Article
  5. 5

    Significance of HLA Nondependent Risk Factors of Chronic Transplant Nephropathy for the Development of Endothelial Dysfunction After Kidney Transplantation by Horcicka, V, Zadrazil, J, Karasek, D, Al JAbry, S, Krejci, K, Strebl, P, Halenka, M, Elfmark, M

    Published in Transplantation proceedings (01-06-2009)
    “…Abstract More than 40% of renal allografts show chronic transplant nephropathy (CTN) early after renal transplantation. Cardiovascular disease is the leading…”
    Get full text
    Journal Article
  6. 6

    Changes in Bone Mineral Density and Selected Metabolic Parameters Over 24 Months Following Renal Transplantation by Al-Gabri, S., Zadražil, J., Krejčı́, K., Horák, P., Bachleda, P.

    Published in Transplantation proceedings (01-03-2005)
    “…Our aim was to evaluate changes in serum levels of selected bone metabolism indicators and bone density over 24 months following renal transplant. A partial…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8

    Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease by Žamboch, K., Krejčí, K., Škarda, J., Tichý, M., Überall, I., Skýpalová, P., Langová, K., Stejskal, D., Švesták, M., Zahálková, J., Ščudla, V., Zadražil, J.

    Published in International urology and nephrology (01-07-2015)
    “…Summary Chronic kidney disease–mineral and bone disorder (CKD–MBD) ranks among clinically and pathogenetically significant complications in patients with CKD…”
    Get full text
    Journal Article
  9. 9

    Aetiology and a clinical picture of chronic renal failure by Zadrazil, J

    Published in Vnitřní lékar̆stvĭ (01-07-2011)
    “…The term chronic renal failure (CRF) usually means the final stage of chronic kidney disease (CKD) with a decline in glomerular filtration rate (GF) below 0.25…”
    Get more information
    Journal Article
  10. 10

    Protocol Biopsy of a Transplanted Kidney as a Tool for Monitoring Adequacy of Immunosuppressive Therapy: 10 Years of Experience From a Single Transplant Center by Krejčí, K, Tichý, T, Al-Gabri, S, Horák, P, Ciferská, H, Hrubý, M, Horčička, V, S̆trebl, P, Z̆amboch, K, Bachleda, P, Zadraz̆il, J

    Published in Transplantation proceedings (01-06-2011)
    “…Abstract Background The aims of this prospective study were to determine the prevalence of clinically silent rejection changes and of nephrotoxicity of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Nonsteroidal antiinflammatory drugs and the kidney by Zadrazil, J

    Published in Vnitřní lékar̆stvĭ (01-07-2006)
    “…Nonsteroidal antiinflammatory drugs (NSAIDs) have potentially important renal adverse effects. With regard to renal adverse effects there is no indication of…”
    Get more information
    Journal Article
  13. 13

    Single photon bone densitometry in hemodialysis patients by Jaros, A, Zadrazil, J, Konecný, K, Kosatíková, Z, Zahálková, J, Vrublovský, P, Krejcí, K

    “…Renal osteodystrophy is a common finding in patients with renal insufficiency. The maximum of its intensity is found in hemodialysis patients. Bone…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels by Scudla, V, Budíková, M, Fischerová, E, Zadrazil, J, Indrák, K

    “…In 71 patients with multiple myeloma the authors evaluated the clinical significance and the prognostic relevance of Bataille's stratification system based on…”
    Get more information
    Journal Article
  18. 18

    IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of 'psoriatic nephropathy' by Zadrazil, Josef, Tichý, Tomás, Horák, Pavel, Nikorjaková, Iva, Zíma, Pavel, Krejcí, Karel, Strébl, Pavel

    Published in Journal of nephrology (01-05-2006)
    “…It is generally accepted that there is no higher prevalence of renal disease in psoriatic patients, except in the case of secondary renal amyloidosis in…”
    Get more information
    Journal Article
  19. 19
  20. 20